[A Case of Rupture of Esophageal Varices during a Course of CAPOX with Bevacizumab Therapy for Sigmoid Colon Cancer with Multiple Liver Metastases]

Gan To Kagaku Ryoho. 2019 Dec;46(13):2360-2362.
[Article in Japanese]

Abstract

The patient was a 67-year-old man with multiple liver metastases from sigmoid colon cancer and had received capecitabine, oxaliplatin, and bevacizumab(CAPOX plus Bev)combination chemotherapy. After 11 courses of this therapy, he had a rupture of esophageal varices and was treated with endoscopic variceal ligation(EVL). Esophageal varices are rare during the course of oxaliplatin-based chemotherapy. More studies are necessary for early detection of esophageal varices during this therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bevacizumab
  • Esophageal and Gastric Varices*
  • Esophagus / injuries*
  • Gastrointestinal Hemorrhage
  • Humans
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / secondary
  • Male
  • Neoplasm Recurrence, Local
  • Rupture / chemically induced*
  • Sigmoid Neoplasms* / drug therapy

Substances

  • Bevacizumab